{"slideshow_credits": null, "snippet": "The rising toll has cast a harsh light on the loose regulations that legal experts say allowed a company to sell an unsafe drug to pain clinics.", "abstract": "Rising death toll in the growing national meningitis outbreak has cast harsh light on loose regulations that legal experts say allowed New England Compounding Center, drug company, to sell 17,676 vials of an unsafe drug to pain clinics in 23 states; federal health officials have said that all patients injected with steroid drug made by the company need to be tracked down immediately and informed of the danger.", "section_name": "U.S.", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Denise", "role": "reported", "lastname": "GRADY", "rank": 1, "organization": ""}, {"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 2, "organization": ""}, {"firstname": "Sabrina", "role": "reported", "lastname": "TAVERNISE", "rank": 3, "organization": ""}], "original": "By DENISE GRADY, ANDREW POLLACK and SABRINA TAVERNISE", "contributor": "Jess Bidgood and Sheelagh McNeill contributed reporting."}, "web_url": "http://www.nytimes.com/2012/10/07/us/scant-drug-maker-oversight-in-meningitis-outbreak.html", "lead_paragraph": "The rising toll has cast a harsh light on the loose regulations that legal experts say allowed a company to sell an unsafe drug to pain clinics.", "headline": {"seo": "Scant Drug Maker Oversight in Meningitis Outbreak", "main": "Scant Oversight of Drug Maker in Fatal Meningitis Outbreak", "print_headline": "Scant Oversight of Drug Maker in Fatal Outbreak"}, "_id": "507c507795e998af71186ae8", "word_count": "2105", "multimedia": [{"height": 75, "url": "images/2012/10/07/us/SUB-MENINGITIS-1/SUB-MENINGITIS-1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/10/07/us/SUB-MENINGITIS-1/SUB-MENINGITIS-1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-10-07T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "New England Compounding Center", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Meningitis", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "4"}, {"value": "Health Insurance and Managed Care", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Factories and Manufacturing", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Deaths (Fatalities)", "name": "subject", "is_major": "N", "rank": "8"}, {"value": "Pain-Relieving Drugs", "name": "subject", "is_major": "Y", "rank": "9"}, {"value": "Steroids", "name": "subject", "is_major": "Y", "rank": "10"}], "blog": [], "subsection_name": null, "type_of_material": "News"}